SciY is being launched by Bruker’s new Integrated Data Solutions division, in close collaboration with majority-owned software companies Mestrelab Re...
The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to the Saphyr® i...
- Gilead Sciences K.K. is Now Marketing Authorization Holder -- -- Kite Cell Therapy Business Unit of Gilead Sciences K.K. will manage the product’s...
Validation is a required component of medical device quality assurance. But device manufactures new to CMMs find it challenging to validate the software an...
In another unique public-private sector partnership that raises Dubai’s global competitiveness as a hub for advanced technologies and smart applicati...
BurstIQ, a trusted leader in data-driven healthcare solutions, proudly announces the acquisition of Olive AI's business intelligence solution. This...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new automated i...
Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to an...
Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today ...
Wolters Kluwer Health announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-base...
In this collaboration, Iktos’ de novo generative design technology in combination with Curreio’s state-of-the-art cryo-EM platform will be used...
Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio High potency ionizable li...
PathomIQ is a leading provider of AI-enabled tools for prostate, breast, lung and other cancers that enable precision medicine by extracting yet untapped i...
Gives Nordic Nanovector access to highly promising new technology that enables the development and production of radionuclides for radioimmunoconjugate-b...
© 2025 Biopharma Boardroom. All Rights Reserved.
